These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11785465)

  • 1. Viro diversity (or, keeping up with HIV's evolutionary caprice).
    Mascolini M
    IAPAC Mon; 2001 Jul; 7(7):198-207. PubMed ID: 11785465
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV drug resistance testing: an update for the clinician.
    Rice HL; Zolopa AR
    AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Incorporation of the test of resistance to antiretroviral drugs in clinical practice].
    Soriano V; Briones C
    Med Clin (Barc); 1999 Mar; 112(11):412-5. PubMed ID: 10231774
    [No Abstract]   [Full Text] [Related]  

  • 4. [Resistance to non-nucleoside reverse transcriptase inhibitors].
    Casado JL; López JC; Viciana P
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):30-3. PubMed ID: 11428057
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV resistance testing benefit is shown.
    AIDS Alert; 2001 Oct; 16(10):136. PubMed ID: 11590937
    [No Abstract]   [Full Text] [Related]  

  • 6. Putting resistance to the test.
    Daar ES
    Posit Living; 2001 Apr; 10(3):15-6, 43-6. PubMed ID: 11548369
    [No Abstract]   [Full Text] [Related]  

  • 7. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
    Mascolini M; Wensing AM; Boucher CA
    IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306
    [No Abstract]   [Full Text] [Related]  

  • 8. [GESIDA Consensus document on the use of resistance studies in clinical practice].
    Gatell JM; Blanco JL; Alcamí J; Antela A; Arrizabalaga J; Casado JL; Clotet B; Delgado R; Erice A; Guerra L; Guerrero A; Iribarren JA; Leal M; López JC; Menéndez-Arias L; Miró JM; Moreno S; Pérez JL; Pumarola T; Rubio R; Ruiz L; Santamaría JM; Soriano V; Telenti A; Viciana P
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):53-60. PubMed ID: 11428062
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretroviral drug resistance mutations in antiretroviral-naive prisoners.
    Stone DR; Corcoran C; Wurcel A; McGovern B; Quirk J; Brewer A; Sutton L; D'Aquila RT
    Clin Infect Dis; 2002 Oct; 35(7):883-6. PubMed ID: 12228827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV susceptibility determination: a qualified position against regarding a complex technology].
    Telenti A
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):45-6. PubMed ID: 11428060
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV suppression and risk of drug resistance mutations.
    Phillips AN; Loveday C; Johnson MA
    AIDS; 1998 Oct; 12(14):1930. PubMed ID: 9792396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary resistance to antiretroviral agents].
    Soriano V; María Miró J; Guerrero A
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):22-5. PubMed ID: 11428054
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance investigations during HIV-therapy is necessary].
    Schattenfroh S
    Dtsch Med Wochenschr; 1998 Feb; 123(7):A7. PubMed ID: 9505940
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of Viroseq-HIV version 2 for HIV drug resistance.
    Mukaide M; Sugiura W; Matuda M; Usuku S; Noguchi Y; Suzuki K; Kawata K; Ito A; Sagara H; Yamada K; Kondo M; Imai M
    Jpn J Infect Dis; 2000 Oct; 53(5):203-5. PubMed ID: 11135705
    [No Abstract]   [Full Text] [Related]  

  • 15. What is the difference between phenotyping and genotyping?
    Wilder TL
    Surviv News (Atlanta Ga); 2001 May; ():13, 20. PubMed ID: 11682727
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV drug resistance testing: data be damned.
    Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV drug resistance: overview of clinical data.
    Miller V
    J HIV Ther; 2001 Aug; 6(3):68-71. PubMed ID: 11555740
    [No Abstract]   [Full Text] [Related]  

  • 18. New insights into HIV resistance testing: nursing guidelines and implications.
    Kirton CA; Kurtyka D; Sterken DJ
    J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically validated genotype analysis: guiding principles and statistical concerns.
    Brun-Vézinet F; Costagliola D; Khaled MA; Calvez V; Clavel F; Clotet B; Haubrich R; Kempf D; King M; Kuritzkes D; Lanier R; Miller M; Miller V; Phillips A; Pillay D; Schapiro J; Scott J; Shafer R; Zazzi M; Zolopa A; DeGruttola V
    Antivir Ther; 2004 Aug; 9(4):465-78. PubMed ID: 15456077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.